Skip to content
Search

Latest Stories

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals
75 per cent of adults in England are registered for digital prescriptions on the NHS App

In a groundbreaking move towards modernising healthcare, England's National Health Service (NHS) has successfully implemented digital prescriptions, as reported by the World Health Organization (WHO) in its latest regional digital health report.

Since January 2024, patients across England have had access to their prescription information through the NHS App, marking a significant leap in healthcare accessibility and efficiency.


With over 33 million registered users, representing 75 per cent of the adult population, the NHS App has become a vital tool in managing healthcare online.

The introduction of digital prescriptions allows users to order repeat prescriptions online without the need for a GP visit.

This innovation has witnessed a surge in digital requests, with over 3.1 million repeat prescriptions processed monthly.

Notably, this digital approach saves GPs an average of three minutes per prescription, leading to substantial time and cost savings for health centers.

Moreover, the launch of Pharmacy First has aided the NHS to lessen the burden on the GPs as pharmacies are assisting patients for common conditions including sore throat, shingles and  uncomplicated cases of UTIs. 

The report revealed that Pharmacy First scheme "is likely to lead to an increase in patients visiting pharmacies, so the App’s efficiencies for prescriptions will become ever more important".

Natasha Lane, Senior Programme Manager for Digital Medicines at NHS England, highlighted the gradual rollout and refinement of digital prescriptions, emphasising the importance of user feedback in enhancing the App's functionality and usability.

Commenting on the user experience and accessibility, she said "patients no longer have the inconvenience of having to go to a prescriber to collect a paper barcode.”

The benefits extend beyond healthcare providers, with Secretary of State for Health and Social Care Victoria Atkins acknowledging the tool's role in alleviating pressure on pharmacists and GPs, thereby reducing waiting lists and improving patient care.

Moreover, the integration of digital prescriptions into the NHS App enhances transparency within the healthcare system, empowering patients to take ownership of their health.

With over 500,000 weekly views of digital prescriptions, patients can now conveniently access their prescription information and address any concerns promptly, ultimately reducing delays and streamlining the healthcare process.

Furthermore, the WHO's report underscores England's pioneering role in digital healthcare within the European Region.

While England leads with digital prescription implementation, other European countries have also embraced electronic prescriptions, with some even establishing interoperable systems for cross-border prescriptions.

This digital transformation aligns with WHO/Europe's strategic objectives to enhance patient safety, quality of care, and universal health coverage.

By leveraging digital tools, healthcare systems can effectively address the evolving needs of patients and healthcare professionals alike.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less